New data presented today raise the question of whether patients with severe Hepatitis C virus (HCV) should be treated with direct-acting antivirals (DAAs), given their high risk of short-term death at this late-disease stage.
Apr 14, 2016
Researchers today demonstrated that a scoring system can predict a person's risk of death from non-alcoholic fatty liver disease (NAFLD), the world's most prevalent liver disease. The study results were presented today at ...
Apr 14, 2016
New research presented today at The International Liver Congress 2016 in Barcelona, Spain has uncovered a genetic link that explains why certain people with alcohol dependence are more susceptible to developing severe alcoholic ...
Apr 14, 2016
New data presented today at The International Liver Congress 2016 in Barcelona, Spain, demonstrates a high sustained virologic response (SVR) at 12 weeks from the all-oral combination of sofosbuvir/velpatasvir and experimental ...
Apr 14, 2016
